Generative AI Patient Education Module for Breast Oncology
Recruiting · NCT07512271 · Interventional (participants receive a specific treatment) · Lead sponsor: University of California, San Francisco
View the official record on ClinicalTrials.gov →Interventions studied
OpenEvidence CareConnectSurvey (Participant)Survey (Provider)
What this trial is about
This study evaluates the safety, accuracy, and impact of an artificial intelligence (AI) tool designed to support patient education in breast cancer care for breast oncology patients under selected physicians care within the University of California, San Francisco breast cancer center and affiliate sites.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Females or males ages 18 and over.
- Patients must have either:
- Stage IV breast cancer facing a treatment change and are expected to have follow-up visits at least once every three months, or
- Stage I-III breast cancer diagnosed within the past 6 months.
- Basic computer literacy and regular internet access at home.
- Able to understand study procedures and to comply with them for the entire length of the study.
- Ability of individual or legal guardian/representative to understand a written informed consent document, and the willingness to sign it.
Exclusion criteria
- Contraindication to any study-related procedure or assessment.
- Cognitive impairment that would interfere with tool usage or survey completion
Where it is running
1 location listed across 1 US state.
- University of California, San Francisco - San Francisco, California, United States